Victoria Weston

1.4k citations

19 papers · 958 indexed · h-index 13

Molecular Biology
Oncology top 10%
Cellular and Molecular Neuroscience top 10%
Genetics top 5%
Pathology and Forensic Medicine top 10%

Co-authors: Tatjana Stanković A. Malcolm R. Taylor Paul Moss Jonathan M. Boutell P S Harper P. Thomas J. W. Neal James A. Duce
Topics: Acute Lymphoblastic Leukemia research (8 papers)Chronic Lymphocytic Leukemia Research (6 papers)DNA Repair Mechanisms (5 papers)
Cited by: Genetics Cellular and Molecular Neuroscience Oncology
Journals: Blood Oncogene Scientific Reports
Partner nations: United Kingdom United States United Arab Emirates

In The Last Decade

Victoria Weston

19 papers receiving 946 citations

Peers

Countries citing papers authored by Victoria Weston

Since Specialization

Citations

This map shows the geographic impact of Victoria Weston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Weston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Weston more than expected).

Fields of papers citing papers by Victoria Weston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Weston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Weston. The network helps show where Victoria Weston may publish in the future.

Co-authorship network of co-authors of Victoria Weston

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Weston. A scholar is included among the top collaborators of Victoria Weston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Weston. Victoria Weston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model 2019 ·Scientific Reports ·Helio Pais,Katia Ruggero,Jing Zhang,Osama Al‐Assar,Nicolas Béry,(unknown),Victoria Weston,Pamela Kearns,Cristina Mecucci,Ami Miller,Terence H. Rabbitts	10
2	The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia 2018 ·Leukemia ·Caroline L. Furness,Marcela Braga Mansur,Victoria Weston,Luca Ermini,Frederik W. van Delft,Sarah Jenkinson,Rosemary E. Gale,Christine J. Harrison,Maria S. Pombo‐de‐Oliveira,Marta Sánchez-Martín,Adolfo A. Ferrando,Pamela Kearns,Ian Titley,Anthony M. Ford,Nicola Potter,Mel Greaves	23
3	Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1 2018 ·Experimental Hematology ·Victoria Weston,Wenbin Wei,Tatjana Stanković,Pamela Kearns	9
4	The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53 2014 ·Oncogene ·(unknown),Tracey Perry,Sarah Berhane,Ceri Oldreive,Anastasia Zlatanou,Luke Williams,Victoria Weston,Tatjana Stanković,Pamela Kearns,Klaus Pors,Roger J.A. Grand,Grant S. Stewart	6
5	BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia 2013 ·Blood Cancer Journal ·David Da Costa,Angelo Agathanggelou,Tracey Perry,Victoria Weston,Eva Petermann,Anastasia Zlatanou,Ceri Oldreive,Wenbin Wei,Grant S. Stewart,(unknown),Emily Smith,Pamela Kearns,Stefan Knapp,Tatjana Stanković	63
6	ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele 2011 ·Haematologica ·Anna Skowrońska,Belinda Austen,Jean Powell,Victoria Weston,David Oscier,Martin J.S. Dyer,Estella Matutes,Guy Pratt,Chris Fegan,Paul Moss,M.A. Taylor,Tatjana Stanković	26
7	Inhibition of BRD4 Bromodomains Is a Potent Novel Strategy to Target Apoptosis Resistance in Paediatric ALL 2011 ·Blood ·David Da Costa,Victoria Weston,Wenbin Wei,Angelo Agathanggelou,Eva Petermann,Stefan Knapp,Pamela Kearns,Tatjana Stanković	1
8	5.2 Combinatory Effect of PARP Inhibition with Existing Low-Toxicity Chromatin Modifying Agents (HDAC Inhibitors) Sensitizes CLL Tumors with DNA Damage Response Defect 2011 ·Clinical Lymphoma Myeloma & Leukemia ·Tatjana Stanković,Angelo Agathanggelou,Ceri Oldreive,Victoria Weston,Paul Moss,A. Malcolm R. Taylor,Guy Pratt	1
9	The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo 2010 ·Blood ·Victoria Weston,Ceri Oldreive,Anna Skowrońska,David Oscier,Guy Pratt,Martin J.S. Dyer,Graeme C.M. Smith,(unknown),Zbigniew Rudzki,Pamela Kearns,Paul Moss,A. Malcolm R. Taylor,Tatjana Stanković	229
10	Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia 2009 ·Epigenetics ·Thomas L. Dunwell,Rachel Dickinson,Tatjana Stanković,Ashraf Dallol,Victoria Weston,Belinda Austen,Daniel Catchpoole,Eamonn R. Maher,Farida Latif	40
11	Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response 2008 ·Blood ·(unknown),Victoria Weston,(unknown),Esther N. Maina,Carmel McConville,Angelo Agathanggelou,Anna Skowrońska,(unknown),Katrin Sameith,Judith E. Powell,Sarah Lawson,Pamela Kearns,Francesco Falciani,A. Malcolm R. Taylor,Tatjana Stanković	16
12	A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival 2005 ·Blood ·Azra Alvi,Belinda Austen,Victoria Weston,Chris Fegan,David E. MacCallum,Athos Gianella-Borradori,David P. Lane,Michael Hubank,Judith E. Powell,Wenbin Wei,A. Malcolm R. Taylor,Paul Moss,Tatjana Stanković	111
13	Japanese Painting and National Identity 2004 ·Victoria Weston	5
14	Rac1 and Rac2 GTPases in haematopoiesis 2004 ·BioEssays ·Victoria Weston,Tatjana Stanković	12
15	Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-κB survival pathway signaling 2004 ·Blood ·Victoria Weston,Belinda Austen,Wenbin Wei,(unknown),Azra Alvi,Sarah Lawson,Philip Darbyshire,Mike Griffiths,Frank G. H. Hill,(unknown),Paul Moss,A. Malcolm R. Taylor,Tatjana Stanković	46
16	Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses 2003 ·Blood ·Tatjana Stanković,Michael Hubank,(unknown),Grant S. Stewart,Danielle Fletcher,(unknown),Azra Alvi,Belinda Austen,Victoria Weston,Chris Fegan,Philip J. Byrd,Paul Moss,A. Malcolm R. Taylor	79
17	Molecular analysis of single colonies reveals a diverse origin of initial clonal proliferation in B-precursor acute lymphoblastic leukemia that can precede the t(12;21) translocation. 2001 ·PubMed ·Victoria Weston,Carmel McConville,Jillian R. Mann,Philip Darbyshire,Sarah Lawson,John Gordon,Paul Moss,A. Malcolm R. Taylor,Tatjana Stanković	16
18	Clonal Diversity of Ig and T-cell Receptor Gene Rearrangements in Childhood B-Precursor Acute Lymphoblastic Leukaemia 2000 ·Leukemia & lymphoma ·Tatjana Stanković,Victoria Weston,Carmel McConville,(unknown),Judith E. Powell,Jillian R. Mann,(unknown),A. Malcolm R. Taylor	17
19	Aberrant Interactions of Transcriptional Repressor Proteins with the Huntington's Disease Gene Product, Huntingtin 1999 ·Human Molecular Genetics ·Jonathan M. Boutell,P. Thomas,J. W. Neal,Victoria Weston,James A. Duce,P S Harper,A. Lesley Jones	248

About Victoria Weston

Victoria Weston is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Hematology, having authored 19 papers that have together received 958 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and DNA Repair Mechanisms (5 papers). The work is most often cited by research in Genetics (175 citations), Cellular and Molecular Neuroscience (240 citations) and Oncology (337 citations). Victoria Weston has collaborated with scholars based in United Kingdom, United States and United Arab Emirates. Frequent co-authors include Tatjana Stanković, A. Malcolm R. Taylor, Paul Moss, Jonathan M. Boutell, P S Harper, P. Thomas, J. W. Neal, James A. Duce, A. Lesley Jones and Pamela Kearns. Their work appears in journals such as Blood, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact